![MachineMD_RGB_C_DarkBG[5718]](https://www.machinemd.com/hs-fs/hubfs/MachineMD_RGB_C_DarkBG%5B5718%5D.png?width=200&height=26&name=MachineMD_RGB_C_DarkBG%5B5718%5D.png "MachineMD_RGB_C_DarkBG[5718]"){kind=small}
News and Media Releases
machineMD awarded one of the Best Startup Teams of 2022.
5 July 2022
On June 30, machineMD was on the podium receiving a trophy for "Best Startup Team of the Year – powered by BEKB" at the Bern Center for Innovation and Digitalization, ZID. machineMD’s amazing...
machineMD at the Swiss Medtech Day 2022
8 June 2022
The Swiss Medtech Day 2022 will highlight advances in Digital Health Technology. As an innovator in digital health, machineMD has been invited to showcase its winning combination of...
Welcome@machineMD: Phil Norris - Head of Commercial Strategy with a long-standing interest in digital health and applications of virtual reality
4 May 2022
Phil Norris has just joined machineMD as Head of Commercial Strategy. He looks towards the launch of the NeurOphthalmoscope by planning how machineMD can best provide value to Neurologists and...
"We are making specialist expertise available to every ophthalmologist and neurologist."
12 April 2022
Professor Mathias Abegg, MD, is a neuro-ophthalmologist. He is the medical director of machineMD. In his everyday medical work, he deals with eye movement disorders such as strabismus....
Successful cooperation with CSEM
8 April 2022
In November 2021, machineMD and CSEM Neuchâtel launched their joint Innosuisse project, which will last 1.5 years.
CSEM is a Swiss private, non-profit research and technology organization with...
machineMD @ Impact Circle Event Gstaad
22 February 2022
In mid-February, machineMD presented its project at the Impact Circle Event Gstaad, which was all about sustainability and healthcare. machineMD showed an interesting audience of...
First financing round successfully closed
16 December 2021
MachineMD has successfully closed a financing round of CHF 1.4m. We are developing a diagnostic platform for early detection of neurodegenerative diseases based on eye and pupil movements. The...
Innosuisse project for MachineMD
9 December 2021
We are proud to announce our Innosuisse project with a project volume of CHF 1.257m which supports the development of neos™, our diagnostic platform.
Project partners are Helbling AG in Bern, ...